World's Best Scientists 2026 revealed!
Francesco Cognetti

Francesco Cognetti

D-Index & Metrics

Medicine

D-Index
82
Citations
36192
World Ranking
15881
National Ranking
621

Overview

Francesco Cognetti is affiliated with the Sapienza University of Rome in Italy. Their primary field of research is Medicine, with a focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Molecular Biology. Their work encompasses several specialized topics, notably Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, CAR-T cell therapy research, HER2/EGFR in Cancer Research, Radiomics and Machine Learning in Medical Imaging, and Immunotherapy and Immune Responses.

Their recent published works include:

  • Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial, 2021, The Lancet Oncology
  • Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma, 2020, Journal of Clinical Oncology
  • Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach, 2021, Frontiers in Oncology
  • The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream study, 2022, Frontiers in Oncology
  • Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP), 2024, Journal of Clinical Oncology

Frequent coauthors who have collaborated extensively with Francesco Cognetti include:

  • Paolo Marchetti
  • Paolo A. Ascierto
  • Alessandra Fabi
  • Diana Giannarelli
  • Michelino De Laurentiis

The principal publication venues where Francesco Cognetti's work appears most frequently are:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Frontiers in Oncology
  • Tumori Journal
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • Nivolumab in previously untreated melanoma without BRAF mutation.

    Caroline Robert;Georgina V. Long;Benjamin Brady;Caroline Dutriaux

  • Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

    Jacques Bernier;Christian Domenge;Mahmut Ozsahin;Katarzyna Matuszewska

  • Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

    Michael Marty;Francesco Cognetti;Dominique Maraninchi;Raymond Snyder

  • Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

    Eric Pujade-Lauraine;Jonathan A Ledermann;Frédéric Selle;Val Gebski

  • Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non–Small-Cell Lung Cancer

    Giorgio V. Scagliotti;Roldano Fossati;Valter Torri;Lucio Crinò

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.

    Serrone L;Zeuli M;Sega Fm;Cognetti F

  • PTEN: Multiple Functions in Human Malignant Tumors

    Michele Milella;Italia Falcone;Fabiana Conciatori;Ursula Cesta Incani

  • Cancer in the elderly: why so badly treated?

    I.S. Fentiman;U. Tirelli;S. Monfardini;M. Schneider

  • A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

    Andrea Alimonti;Caterina Nardella;Zhenbang Chen;John G. Clohessy

  • Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

    Donatella Del Bufalo;Ludovica Ciuffreda;Daniela Trisciuoglio;Marianna Desideri

  • Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy

    Andrea Pace;Antonella Savarese;Mauro Picardo;Vittoria Maresca

  • Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck A phase III study of the EORTC Head and Neck Cancer Cooperative Group

    M. Clavel;J. B. Vermorken;F. Cognetti;P. Cappelaere

  • Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

    F Roila;M Tonato;F Cognetti;E Cortesi

  • Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

    Paolo A. Ascierto;Georgina V. Long;Georgina V. Long;Caroline Robert;Benjamin Brady

  • Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy

    Henri Roché;Louise Yelle;Francesco Cognetti;Louis Mauriac

  • Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

    F. Cognetti;E. M. Ruggeri;A. Felici;M. Gallucci

  • Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial

    A. Pace;D. Giannarelli;E. Galiè;A. Savarese

  • HER2 and response to paclitaxel in node-positive breast cancer.

    Gianluigi Ferretti;Alessandra Felici;Francesco Cognetti

  • Neuroprotective E ffect o f V itamin E S upplementation i n Patients T reated W ith C isplatin C hemotherapy

    Andrea Pace;Antonella Savarese;Mauro Picardo;Vittoria Maresca

Frequent Co-Authors

Diana Giannarelli
Diana Giannarelli Sapienza University of Rome
Michele Milella
Michele Milella University of Verona
Marcella Mottolese
Marcella Mottolese IRCCS Regina Elena Institute
Giampaolo Tortora
Giampaolo Tortora University of Verona
Mario Mandalà
Mario Mandalà European Institute of Oncology
Sandro Barni
Sandro Barni Mario Negri Institute for Pharmacological Research
Sabino De Placido
Sabino De Placido University of Naples Federico II
Alfredo Falcone
Alfredo Falcone University of Pisa
Michele Maio
Michele Maio University of Siena
James A. McCubrey
James A. McCubrey East Carolina University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn’t always mean taking the traditional route. Many students today are considering flexible online options that lead to rewarding healthcare roles. For nurses looking to advance, cheap rn to bsn programs offer a cost-effective way to build on your nursing credentials while working.

For those who don’t have a nursing background but want to enter advanced nursing roles, direct entry nurse practitioner programs for non-nurses online provide a pathway to an MSN and a faster route into nurse practitioner positions.

If you’re at the beginning of your healthcare journey, consider the online adn programs for non nurses. These programs make it possible for students without prior nursing experience to earn their associate degree in nursing through flexible study options.

Not all healthcare careers require patient care. For those interested in the administrative side of medicine, check out the best medical billing and coding schools online, where you can study remotely and access financial aid opportunities.

Best Scientists Citing Francesco Cognetti

Trending Scientists

Recently Published Articles